Drawing for MAC CLINICAL RESEARCH

USPTO serial 79343442

MAC CLINICAL RESEARCH

Reviewed by CopyMark Law Group

Reg. 7369379Status 700Registered
Filing date
Status date
Registration date
Apr 30, 2024
Examiner
GAINES, LEAH R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MAC CLINICAL RESEARCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Janet F. Satterthwaite

Janet F. Satterthwaite Potomac Law Group, PLLC1717 Pennsylvania Avenue, NW, Suite 1025Washington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Advisory services relating to scientific research, contract research services in the field of pharmaceuticals and the clinical sector; research and development of new products; laboratory research services relating to pharmaceuticals; management of scientific research projects, namely, consulting services for others in the field of design, planning and implementation, project management of scientific research, pharmaceutical research and clinical trials; medical research; pharmaceutical research services; preparation of reports relating to scientific research; provision of information relating to scientific research; provision of research services in the field of pharmaceuticals and the clinical sector; scientific research; research and development for others in the field of pharmaceuticals and the clinical sector; research into new products; research relating to biotechnology; research relating to medicine; research relating to medicines; research relating to pharmaceuticals; scientific research into the development of new productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 17, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 25, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 25, 2024FIMPFINAL DISPOSITION PROCESSED—
Jul 30, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 1, 2024GPNXNOTIFICATION PROCESSED BY IB—
Apr 30, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 30, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 30, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 13, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 13, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 24, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 24, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 10, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 18, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 29, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 29, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 7, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 2, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 2, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 2, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 2, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 2, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 6, 2023RFNTREFUSAL PROCESSED BY IB—
May 8, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 8, 2023RFRRREFUSAL PROCESSED BY MPU—
Mar 18, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 17, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2023DOCKASSIGNED TO EXAMINER—
Jun 28, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 24, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 23, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance